Not Yet RecruitingNot Applicable

Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project

United States300 participantsStarted 2025-09-30

Plain-language summary

To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection. * Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care. Exclusion Criteria: • Patients who are unwilling to undergo routine diagnostic procedures as part of their regular care.

What they're measuring

Safety and Adverse Events (AEs)

Timeframe: Through study completion; an average of 1 year.

Trial details

NCT IDNCT06878144

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12-31

Contact for this trial

Dimitrios Kontoyiannis, MD

(713) 792-0826 dkontoyi@mdanderson.org

View on ClinicalTrials.gov More Mucormycosis trials